Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention

Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention

Paperback(Softcover reprint of the original 1st ed. 1994)

$139.00
Want it by Wednesday, November 21 Order now and choose Expedited Shipping during checkout.

Product Details

ISBN-13: 9783642856624
Publisher: Springer-Verlag New York, LLC
Publication date: 02/17/2012
Edition description: Softcover reprint of the original 1st ed. 1994
Pages: 202
Product dimensions: 6.69(w) x 9.61(h) x 0.02(d)

Table of Contents

Arteriosclerosis: Its morphology in the past and today.- Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries.- Lipid and cellular constituents of unstable human aortic plaques.- Immunological control mechanisms in plaque formation.- Proliferation versus atrophy - the ambivalent role of smooth muscle cells in human atherosclerosis.- Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis.- Vascular renin-angiotensin-system, endothelial function and atherosclerosis?.- Endothelial dysfunction in atherosclerosis.- New determinants of the uptake of atherogenic plasma proteins by arteries.- Hyperlipidemic endothelial injury and angiogenesis.- Assessment of endothelial modulation of coronary vasomotor tone: Insights into a fundamental functional disturbance in vascular biology of atherosclerosis.- In vitro assessment of luminal dimensions of coronary arteries by intravascular ultrasound with and without application of echogenic contrast dye.- Therapeutic approaches to the control of coronary atherosclerosis.- Role of calcium in arteriosclerosis - Experimental evaluation of antiarteriosclerotic potencies of Ca antagonists.- Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience..- I: Preventive effects of calcium antagonists in animal experiments.- II: Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.- Lipid-lowering therapy - Implications for the prevention of atherosclerosis.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews